Abbonarsi

Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction—A prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial) - 07/08/11

Doi : 10.1016/j.ahj.2009.10.024 
Mark A. Kotowycz, MD, MBA, FRCPC a, b, Tammy L. Cosman, RN, MN, ACNP a, Corinne Tartaglia, RN, MScN a, Rizwan Afzal, MSc a, Renu Pal Syal, BA a, Madhu K. Natarajan, MD, MSc, FRCPC, FACC a, c,
a Population Health Research Institute, Hamilton Health Sciences, Hamilton, Ontario, Canada 
b Division of Cardiology, McGill University, Montréal, Québec, Canada 
c Division of Cardiology, McMaster University, Hamilton, Ontario, Canada 

Reprint requests: Madhu Natarajan, MD, MSc, FRCPC, FACC, Hamilton Health Sciences—General Site, McMaster Clinics, Room 263, 237 Barton Street East, Hamilton, Ontario, Canada, L8L 2X2.

Riassunto

Background

Patients with ST-segment elevation myocardial infarction (STEMI) have traditionally been hospitalized for 5 to 7 days to monitor for serious complications such as heart failure, arrhythmias, reinfarction, and death. The Zwolle Primary Percutaneous Coronary Intervention (PCI) Index is an externally validated risk score that has been used to identify low-risk STEMI patients who have undergone primary PCI and can safely be discharged from hospital within 72 hours. Previous studies have shown that many low-risk patients remain in hospital significantly longer.

Methods

We randomly assigned 54 low-risk STEMI patients treated with primary or rescue PCI to 1 of 2 groups. Patients in the intervention group (n = 27) were actively targeted for early hospital discharge (48-72 hours) and received outpatient follow-up with an advanced practice nurse (APN). In the control group (n = 27), discharge planning and follow-up were left to the treating physician, and there was no added nursing intervention. The 2 primary outcomes of this pilot study were to demonstrate feasibility and safety. Secondary outcomes included compliance with medications, smoking cessation, attendance at cardiac rehabilitation, and quality of life, measured in both groups at 6 weeks time.

Results

In the intervention group, 74% of patients were discharged within 72 hours, 100% had follow-up with the APN within 3 days (74% in person, 26% by phone), and 100% had ≥ 3 APN follow-ups in total, meeting our prespecified criteria for feasibility. The median length of stay was 55 hours in both groups. There were no deaths in either group, and there was no difference in rehospitalization between patients in the intervention and control groups (8% vs 4%, P = .56). There was no difference in rates of medication compliance, smoking cessation, attendance at cardiac rehabilitation, or quality of life between the 2 groups, although our small pilot study was not powered to detect a difference in these outcomes.

Conclusion

In low-risk STEMI patients treated with primary or rescue PCI, a strategy of early hospital discharge facilitated by close nursing follow-up is feasible. Although our study did not identify differences in compliance or quality of life between the 2 groups, it did provide a functional study design for a larger trial powered to detect these important clinical end points.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 www.clinicaltrials.gov #NCT00474214
 Sources of funding: McMaster Internal Medicine resident research grant. Regional Medical Associates (RMA) resident research scholarship.


© 2010  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 159 - N° 1

P. 117.e1-117.e6 - Gennaio 2010 Ritorno al numero
Articolo precedente Articolo precedente
  • Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial
  • Harvey D. White, Philip E. Aylward, Richard Gallo, Christoph Bode, Gabriel Steg, Steven R. Steinhubl, Gilles Montalescot, for the STEEPLE Investigators
| Articolo seguente Articolo seguente
  • The incidence and clinical predictors of early stent thrombosis in patients with acute coronary syndrome
  • Roy Beinart, Raed Abu Sham'a, Amit Segev, Hanoch Hod, Victor Guetta, Michael Shechter, Valentina Boyko, Shlomo Behar, Shlomi Matetzky

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.